GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » Cyclically Adjusted PS Ratio

Evolent Health (STU:9EH) Cyclically Adjusted PS Ratio : 2.07 (As of Jun. 10, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evolent Health Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Evolent Health's current share price is €21.60. Evolent Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €10.43. Evolent Health's Cyclically Adjusted PS Ratio for today is 2.07.

The historical rank and industry rank for Evolent Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:9EH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.86   Med: 2.78   Max: 3.23
Current: 2.06

During the past years, Evolent Health's highest Cyclically Adjusted PS Ratio was 3.23. The lowest was 1.86. And the median was 2.78.

STU:9EH's Cyclically Adjusted PS Ratio is ranked worse than
62.5% of 344 companies
in the Healthcare Providers & Services industry
Industry Median: 1.19 vs STU:9EH: 2.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Evolent Health's adjusted revenue per share data for the three months ended in Mar. 2024 was €5.156. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €10.43 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Evolent Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Evolent Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Cyclically Adjusted PS Ratio Chart

Evolent Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3.10

Evolent Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.61 3.10 2.88

Competitive Comparison of Evolent Health's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, Evolent Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Evolent Health's Cyclically Adjusted PS Ratio falls into.



Evolent Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Evolent Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=21.60/10.43
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Evolent Health's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.156/131.7762*131.7762
=5.156

Current CPI (Mar. 2024) = 131.7762.

Evolent Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.253 100.684 0.331
201509 0.868 100.392 1.139
201512 0.701 99.792 0.926
201603 1.053 100.470 1.381
201606 1.181 101.688 1.530
201609 1.244 101.861 1.609
201612 1.597 101.863 2.066
201703 1.888 102.862 2.419
201706 1.602 103.349 2.043
201709 1.287 104.136 1.629
201712 1.285 104.011 1.628
201803 1.503 105.290 1.881
201806 1.600 106.317 1.983
201809 1.648 106.507 2.039
201812 2.156 105.998 2.680
201903 2.206 107.251 2.710
201906 2.064 108.070 2.517
201909 2.385 108.329 2.901
201912 0.828 108.420 1.006
202003 2.361 108.902 2.857
202006 2.261 108.767 2.739
202009 2.388 109.815 2.866
202012 2.206 109.897 2.645
202103 2.134 111.754 2.516
202106 2.157 114.631 2.480
202109 2.204 115.734 2.509
202112 2.488 117.630 2.787
202203 3.013 121.301 3.273
202206 3.360 125.017 3.542
202209 3.586 125.227 3.774
202212 3.615 125.222 3.804
202303 3.706 127.348 3.835
202306 3.891 128.729 3.983
202309 4.264 129.860 4.327
202312 4.488 129.419 4.570
202403 5.156 131.776 5.156

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evolent Health  (STU:9EH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Evolent Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Evolent Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolent Health (STU:9EH) Business Description

Traded in Other Exchanges
Address
800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Evolent Health (STU:9EH) Headlines

No Headlines